HemaSphere
(Jun 2022)
P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
- T. Chudnova,
- E. Baryakh,
- Y. Polyakov,
- T. Tolstykh,
- O. Kochneva,
- D. Ivanova,
- E. Misyurina,
- K. Yatskov,
- E. Zhelnova,
- M. Litvinenko,
- K. Kaluzhskaya
Affiliations
- T. Chudnova
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- E. Baryakh
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- Y. Polyakov
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- T. Tolstykh
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- O. Kochneva
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- D. Ivanova
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- E. Misyurina
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- K. Yatskov
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- E. Zhelnova
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- M. Litvinenko
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- K. Kaluzhskaya
- 1 heamatology, Moscow City Clinical Hospital 52, Moscow, Russia
- DOI
-
https://doi.org/10.1097/01.HS9.0000849152.57153.a6
- Journal volume & issue
-
Vol. 6
pp.
1455
– 1456
WeChat QR code